Literature DB >> 24902798

IL-22 enhances CCL20 production in IL-1β-stimulated human gingival fibroblasts.

Yoshitaka Hosokawa1, Ikuko Hosokawa, Satoru Shindo, Kazumi Ozaki, Takashi Matsuo.   

Abstract

CC chemokine ligand 20 (CCL20) is involved in the recruitment of Th17 cells and thus in the exacerbation of periodontal disease, but the effect of simultaneous interleukin (IL)-22 and IL-1β stimulation on CCL20 production in human gingival fibroblasts (HGFs) is uncertain. In this study, we investigated the mechanisms of IL-1β- and/or IL-22-induced CCL20 production in HGFs. A single stimulation of IL-22 could not induce CCL20 production. On the other hand, IL-22 could increase CCL20 production from IL-1β-stimulated HGFs in a dose-dependent manner. C-Jun N terminal kinase (JNK) and inhibitor of nuclear factor κB (IκB)-α phosphorylation were increased in IL-1β- and IL-22-stimulated HGFs. An inhibitor of nuclear factor (NF)-κB decreased IL-1β- and IL-22-induced CCL20 production, though an inhibitor of JNK did not modulate CCL20 production. These data suggest that IL-1β in cooperation with IL-22 could increase Th17 cell accumulation in periodontally diseased tissues to enhance CCL20 production in HGFs.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24902798     DOI: 10.1007/s10753-014-9939-5

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  16 in total

1.  Identification of the functional interleukin-22 (IL-22) receptor complex: the IL-10R2 chain (IL-10Rbeta ) is a common chain of both the IL-10 and IL-22 (IL-10-related T cell-derived inducible factor, IL-TIF) receptor complexes.

Authors:  S V Kotenko; L S Izotova; O V Mirochnitchenko; E Esterova; H Dickensheets; R P Donnelly; S Pestka
Journal:  J Biol Chem       Date:  2000-10-16       Impact factor: 5.157

2.  Activated lymphocyte subsets in adult periodontitis.

Authors:  B Afar; D Engel; E A Clark
Journal:  J Periodontal Res       Date:  1992-03       Impact factor: 4.419

3.  Increased expression of interleukin-22 by synovial Th17 cells during late stages of murine experimental arthritis is controlled by interleukin-1 and enhances bone degradation.

Authors:  Renoud J Marijnissen; Marije I Koenders; Ruben L Smeets; Mark H T Stappers; Cheryl Nickerson-Nutter; Leo A B Joosten; Annemieke M H Boots; Wim B van den Berg
Journal:  Arthritis Rheum       Date:  2011-10

4.  B and T lymphocytes are the primary sources of RANKL in the bone resorptive lesion of periodontal disease.

Authors:  Toshihisa Kawai; Takashi Matsuyama; Yoshitaka Hosokawa; Seicho Makihira; Makoto Seki; Nadeem Y Karimbux; Reginaldo B Goncalves; Paloma Valverde; Serge Dibart; Yi-Ping Li; Leticia A Miranda; Cory W O Ernst; Yuichi Izumi; Martin A Taubman
Journal:  Am J Pathol       Date:  2006-09       Impact factor: 4.307

5.  Relative proportions of mononuclear cell types in periodontal lesions analyzed by immunohistochemistry.

Authors:  D F Lappin; O Koulouri; M Radvar; P Hodge; D F Kinane
Journal:  J Clin Periodontol       Date:  1999-03       Impact factor: 8.728

Review 6.  Involvement of T-lymphocytes in periodontal disease and in direct and indirect induction of bone resorption.

Authors:  M A Taubman; T Kawai
Journal:  Crit Rev Oral Biol Med       Date:  2001

7.  Interleukin-22 (IL-22) activates the JAK/STAT, ERK, JNK, and p38 MAP kinase pathways in a rat hepatoma cell line. Pathways that are shared with and distinct from IL-10.

Authors:  Diane Lejeune; Laure Dumoutier; Stefan Constantinescu; Wiebe Kruijer; Jan Jacob Schuringa; Jean-Christophe Renauld
Journal:  J Biol Chem       Date:  2002-06-26       Impact factor: 5.157

Review 8.  A new inflammatory cytokine on the block: re-thinking periodontal disease and the Th1/Th2 paradigm in the context of Th17 cells and IL-17.

Authors:  S L Gaffen; G Hajishengallis
Journal:  J Dent Res       Date:  2008-09       Impact factor: 6.116

9.  Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides.

Authors:  Spencer C Liang; Xiang-Yang Tan; Deborah P Luxenberg; Riyez Karim; Kyriaki Dunussi-Joannopoulos; Mary Collins; Lynette A Fouser
Journal:  J Exp Med       Date:  2006-09-18       Impact factor: 14.307

10.  Preferential recruitment of CCR6-expressing Th17 cells to inflamed joints via CCL20 in rheumatoid arthritis and its animal model.

Authors:  Keiji Hirota; Hiroyuki Yoshitomi; Motomu Hashimoto; Shinji Maeda; Shin Teradaira; Naoshi Sugimoto; Tomoyuki Yamaguchi; Takashi Nomura; Hiromu Ito; Takashi Nakamura; Noriko Sakaguchi; Shimon Sakaguchi
Journal:  J Exp Med       Date:  2007-11-19       Impact factor: 14.307

View more
  5 in total

Review 1.  Interleukin-22: immunobiology and pathology.

Authors:  Jarrod A Dudakov; Alan M Hanash; Marcel R M van den Brink
Journal:  Annu Rev Immunol       Date:  2015-02-11       Impact factor: 28.527

Review 2.  The role of Th17 cells: explanation of relationship between periodontitis and COPD?

Authors:  Jiaohong Liu; Yuanting Ouyang; Zhiyi Zhang; Siyi Wen; Yixing Pi; Ding Chen; Zhikang Su; Zitian Liang; Lvhua Guo; Yan Wang
Journal:  Inflamm Res       Date:  2022-07-04       Impact factor: 6.986

Review 3.  Chemokine function in periodontal disease and oral cavity cancer.

Authors:  Sinem Esra Sahingur; W Andrew Yeudall
Journal:  Front Immunol       Date:  2015-05-05       Impact factor: 7.561

4.  c-Jun N-terminal kinase in pancreatic tumor stroma augments tumor development in mice.

Authors:  Takeshi Sato; Wataru Shibata; Yohko Hikiba; Yoshihiro Kaneta; Nobumi Suzuki; Sozaburo Ihara; Yasuaki Ishii; Soichiro Sue; Eri Kameta; Makoto Sugimori; Hiroaki Yamada; Hiroaki Kaneko; Tomohiko Sasaki; Tomohiro Ishii; Toshihide Tamura; Masaaki Kondo; Shin Maeda
Journal:  Cancer Sci       Date:  2017-09-18       Impact factor: 6.716

Review 5.  The Crossroads of Periodontitis and Oral Squamous Cell Carcinoma: Immune Implications and Tumor Promoting Capacities.

Authors:  Omnia Elebyary; Abdelahhad Barbour; Noah Fine; Howard C Tenenbaum; Michael Glogauer
Journal:  Front Oral Health       Date:  2021-01-20
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.